Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Income from Continuing Operations (2020 - 2025)

Bio Essence has reported Income from Continuing Operations over the past 6 years, most recently at 1029087.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1029087.0 for Q4 2025, up 3833.58% from a year ago — trailing twelve months through Dec 2025 was 896197.0 (up 157.24% YoY), and the annual figure for FY2025 was 896197.0, up 157.24%.
  • Income from Continuing Operations for Q4 2025 was 1029087.0 at Bio Essence, up from 12998.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BIOE hit a ceiling of 1029087.0 in Q4 2025 and a floor of 1199493.0 in Q3 2024.
  • Median Income from Continuing Operations over the past 5 years was 143262.0 (2021), compared with a mean of 112478.7.
  • Biggest five-year swings in Income from Continuing Operations: crashed 1041.83% in 2024 and later skyrocketed 3833.58% in 2025.
  • Bio Essence's Income from Continuing Operations stood at 90634.0 in 2021, then skyrocketed by 175.76% to 68664.0 in 2022, then tumbled by 366.59% to 183048.0 in 2023, then surged by 84.94% to 27563.0 in 2024, then skyrocketed by 3833.58% to 1029087.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1029087.0 (Q4 2025), 12998.0 (Q3 2025), and 59864.0 (Q2 2025) per Business Quant data.